// App-Quantinova.ai

P641 : Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

Researchers

Presenter

  • Revs, J

Principal Investigators

  • Chaparro, M

  • Gisbert, J.P

  • Mariangela, A

  • Fiorino, G

  • Barberio, B

  • Zingone, F

  • Pisani, A

  • Cassar, D

  • Michalopoulos, G

  • Mantzaris, G

  • Mountaki, K

  • Koutroubakis, I

  • Karmiris, K

  • Katsanos, K

  • Duricova, D

  • Burisch, J

  • Madsen, G.R

  • Maaser, C

  • Naila, A

  • Orfanoudaki, E

  • Milivojevic, V

  • Buisson, A

  • Avedano, L

  • Leone, S

  • Torres, J

  • Ellul, P

Medical Centers

  • Hospital Beatriz angelo, Division of Gastroenterology, Loures, Portugal

  • Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid UAM- and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastrenterology Unit, Madrid, Spain

  • IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Gastroenterology and Endoscopy, Milan, Italy

  • University of Padova, Department of Surgery- Oncology and Gastroenterology DiSCOG- Gastroenterology Unit, Padova, Italy

  • Mater dei Hospital, Division of Gastroenterology, Msida, Malta

  • Tzaneion General Hospital, Gastroenterology Department, Piraeus, Greece

  • Ophthalmiatreion Athinon and Polyclinic Hospitals, Evangelismos, Athens, Greece

  • University Hospital Heraklion, Gastroenterology, Heraklion, Greece

  • Venizelion General Hospital, Department of Gastroenterology, Heraklion-Crete, Greece

  • University and Medical School of Ioannina, Gastrenterology Department, Ioannina, Greece

  • ISCARE, IBD clinical and research centre, Prague, Czech Republic

  • Hvidovre University Hospital- University of Copenhagen, Gastrounit- Medical division, Hvidovre, Denmark

  • Hospital Lüneburg, Gastrenterology Department, Lüneburg, Germany

  • St Mark's National Bowel Hospital, IBD Department, London, United Kingdom

  • Clinical center of Serbia- School of Medicine, Clinic for gastroenterology and hepatology, Belgrade, Serbia

  • Université Clermont Auvergne- Inserm- U- MiSH- USC-INRA iHP- CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France

  • an Federation of Crohns and Ulcerative Colitis Associations, Medical Writing, Brussels, Belgium

  • an Federation of Crohns and Ulcerative Colitis Associations, Medical Writing, Brussels, Belgium

Locations

  • Portugal

  • Spain

  • Italy

  • Malta

  • Greece

  • Czech Republic

  • Denmark

  • Germany

  • United Kingdom

  • Serbia

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved